CTC
IBDX icon

Central Trust Company’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Central Trust Company’s Portfolio IBDX Stock Details IBDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.4M Buy
95,131
+13,545
+17% +$341K 0.04% 235
2026
Q1 		$2.06M Buy
81,586
+42,239
+107% +$1.08M 0.04% 249
2025
Q4 		$1M Buy
39,347
+34,832
+771% +$891K 0.02% 339
2025
Q3 		$116K Buy
4,515
+1,593
+55% +$40.4K ﹤0.01% 671
2025
Q2 		$73.9K Sell
2,922
-269
-8% -$6.67K ﹤0.01% 727
2025
Q1 		$79.7K Buy
3,191
+6
+0.2% +$148 ﹤0.01% 700
2024
Q4 		$78.3K Buy
3,185
+2,199
+223% +$55K ﹤0.01% 703
2024
Q3 		$25.4K Sell
986
-249
-20% -$6.29K ﹤0.01% 910
2024
Q2 		$30.3K Buy
1,235
+25
+2% +$611 ﹤0.01% 870
2024
Q1 		$30K Sell
1,210
-591
-33% -$14.6K ﹤0.01% 899
2023
Q4 		$45.4K Buy
1,801
+101
+6% +$2.41K ﹤0.01% 810
2023
Q3 		$39.9K Buy
1,700
+1,362
+403% +$32.9K ﹤0.01% 810
2023
Q2 		$8.32K Buy
+338
New +$8.37K ﹤0.01% 1048

Other funds holding IBDX

ACA
Aptus Capital Advisors Fairhope, Alabama $14.6B AUM 22.78% 1-Year Est. Return
CIA
Capital Investment Advisors Atlanta, Georgia $7.59B AUM 23.38% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CAI
Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SIC
Sigma Investment Counselors Northville, Michigan $2.05B AUM 18.42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
KA
Klingman & Associates New York $2.35B AUM 23.18% 1-Year Est. Return

Central Trust Company's IBDX Position: Q2 2026 in Review

Central Trust Company increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 17% in Q2 2026, buying an estimated $341K and bringing the position to 95,131 shares worth $2.4M. The position accounts for 0.04% of the portfolio, ranked #235.

Central Trust Company first reported a position in IBDX in Q2 2023 and has held it in 13 quarters since. 229 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

  • Central Trust Company held 95,131 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $2.4M as of Q2 2026.
  • Central Trust Company bought 13,545 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $341K.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 0.04% of Central Trust Company's portfolio in Q2 2026, its #235 holding.
  • Central Trust Company first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q2 2023 and has held it in 13 quarters since.
  • 229 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on Central Trust Company's 13F filing for Q2 2026, filed 31 Jul 2026.